Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tempus AI, Inc. Class A (TEM)
NASDAQ:TEM
TEM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$22.89 - $91.45
Previous CloseN/A
Volume1.41M
Average Volume (3M)14.86M
Market Cap
$12.90B
Enterprise Value$9.38B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta5.23
Next Earnings
Aug 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.10
Shares Outstanding152,401,900
10 Day Avg. Volume21,581,468
30 Day Avg. Volume14,856,034
Standard Deviation0.40
R-Squared0.64
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)27.19
Price to Cash Flow (P/CF)66.30
P/FCF Ratio51.40
Enterprise Value/Market Cap0.73
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit32.77
Enterprise Value/Ebitda-14.41
Forecast
1Y Price Target
$61.67Price Target Upside-28.05% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering7
---
Bulls Say, Bears Say
Bulls Say
Acquisition BenefitsThe Ambry acquisition affords TEM a profitable germline testing lab and offers opportunities to enhance TEM's existing products and expand into new areas.
Bears Say
Revenue Growth ConcernsAmbry's slower long-term revenue growth is dilutive to TEM's standalone long-term growth rate.
Stock ValuationThe stock is up ~100% since its debut, but valuation now sits well above key peers, with shares sitting at 12.5x '25 sales compared to NTRA at 9.4x and GH at 4.6x.
---
Ownership Overview
56.99% Insiders
2.58% Mutual Funds
0.08% Other Institutional Investors
35.85% Public Companies and Individual Investors
TEM FAQ
What was Tempus AI, Inc. Class A’s price range in the past 12 months?
Tempus AI, Inc. Class A lowest stock price was $22.89 and its highest was $91.45 in the past 12 months.
What is Tempus AI, Inc. Class A’s market cap?
Tempus AI, Inc. Class A’s market cap is $12.90B.
When is Tempus AI, Inc. Class A’s upcoming earnings report date?
Tempus AI, Inc. Class A’s upcoming earnings report date is Aug 12, 2025 which is in 172 days.
How were Tempus AI, Inc. Class A’s earnings last quarter?
Tempus AI, Inc. Class A released its earnings results on Nov 04, 2024. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.266 by $0.016.
Is Tempus AI, Inc. Class A overvalued?
According to Wall Street analysts Tempus AI, Inc. Class A’s price is currently Overvalued.
Does Tempus AI, Inc. Class A pay dividends?
Tempus AI, Inc. Class A does not currently pay dividends.
What is Tempus AI, Inc. Class A’s EPS estimate?
Tempus AI, Inc. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tempus AI, Inc. Class A have?
Tempus AI, Inc. Class A has 152,401,900 shares outstanding.
What happened to Tempus AI, Inc. Class A’s price movement after its last earnings report?
Tempus AI, Inc. Class A reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.266. Following the earnings report the stock price went down -10.101%.
Which hedge fund is a major shareholder of Tempus AI, Inc. Class A?
Currently, no hedge funds are holding shares in TEM
---
Tempus AI, Inc. Class A Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$61.67 (-28.05% Downside)
$61.67 (-28.05% Downside)
Blogger Sentiment
Bullish
TEM Sentiment 88%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 3.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $146.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 8.6%
Last 30 Days ▲ 121.3%
Last 30 Days ▲ 121.3%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Company Description
Tempus AI, Inc. Class A
Tempus AI endeavors to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. To accomplish this, we built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Our proprietary technology has allowed us to amass what we consider to be one of the largest libraries of clinical and molecular oncology data in the world. We have launched a suite of different products derived from our Platform, which have gained significant traction over the past five years. To date, our offerings have been used by approximately 95% of the largest public pharmaceutical companies.
---
TEM Company Deck
---
TEM Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Tempus reported a strong quarter with significant revenue growth and strategic expansion through the acquisition of Ambry Genetics. Despite a negative EBITDA, the company showed improvement and is on track towards profitability. Certain challenges remain, such as sustaining high growth in the data business and improving sales force productivity.Read More>---
TEM Stock 12 Month Forecast
Average Price Target
$61.67
▼(-28.05% Downside)
Technical Analysis
Best Analysts Covering TEM
1 Year
1 Year Success Rate
4/4 ratings generated profit
1 Year Average Return
+87.22%
reiterated a buy rating last month
Copying Ryan MacDonald's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +87.22% per trade.
---